Why is Ipca Labs falling/rising?

As of 20-Oct, Ipca Laboratories Ltd's stock price is currently at 1,270.90, reflecting a decrease of 15.45 points or 1.2%. The stock has been underperforming, having lost 6.53% over the last nine consecutive days. It is trading below its moving averages across various time frames, indicating a bearish trend. Additionally, the stock has shown significant underperformance compared to the benchmark Sensex, with a 1-week return of -3.93% against the Sensex's +2.47%. Despite the company declaring positive results over the last five quarters, including a 58.12% growth in PAT and a low debt-to-equity ratio, the stock has generated a return of -22.90% over the past year, which raises concerns about its long-term growth potential. In the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 2.10% over the past month and 7.97% year-to-date. This disparity highlights the stock's struggles, as it has consistently underperformed not only against the Sensex but also against the BSE500 over various periods. The decline in investor participation, with a significant drop in delivery volume, further exacerbates the stock's challenges. While high institutional holdings may provide some stability, the overall sentiment remains negative due to the stock's poor long-term growth prospects and recent performance metrics.